A new therapeutic approach for the treatment of breast cancer using synthesis of liposomes containing silybinin and their characterization
Silybinin, one of the active pharmaceutical ingredients in some medical herbs, has been proven to have anti-cancer effects. The aim of this study was to synthesis and characterize lipid nano-carriers containing silybinin in order to breast cancer treatment.
Lipid nanocarriers were synthesized using a thin film method and the drug was loaded on them. Then the physicochemical properties were evaluated using DLS, AFM and spectrophotometers and their toxicity was measured in comparison with the free form of the drug by MTT assay on BT-474 breast cancer cell line.
The synthesized nano-system with a size of 113.2 nm, zeta potential of -22 ± 1.63 mV, slow release type with appropriate physicochemical properties improves the anti-cancer effects of drug on breast cancer cells.
The results of this study demonstrated that the synthesized system, in addition to having appropriate physicochemical properties, could improve anti-cancer effect of drug.
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.